NCT03803735 Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa
| NCT ID | NCT03803735 |
| Status | Recruiting |
| Phase | — |
| Sponsor | French Africa Pediatric Oncology Group |
| Condition | Pediatric Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2016-01-01 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2016-01-01 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The ultimate aim of this registry is to collect precise information concerning the children coming to oncology units working with the French African Oncology Group. This data will help to plan and provide correct pediatric oncology treatment and care for this population. Collecting the data will give much needed information on numbers, stage, treatment and outcome. The register will give data for local and national health authorities in planning pediatric cancer programs.
Eligibility Criteria
Inclusion Criteria: 1. Any child presenting at any one of the participating units for treatment 2. Any child with any type of cancer 3. Any child or adolescent less than 18 years of age. Exclusion Criteria: 1. No cancer found 2. Age greater than 18 years -
Contact & Investigator
Brenda Mallon, MSc
STUDY DIRECTOR
French Africa Pediatric Oncology Group
Frequently Asked Questions
Who can join the NCT03803735 clinical trial?
This trial is open to participants of all sexes, aged 1 Day or older, up to 18 Years, studying Pediatric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03803735 currently recruiting?
Yes, NCT03803735 is actively recruiting participants. Contact the research team at brenda.mallon@gustaveroussy.fr for enrollment information.
Where is the NCT03803735 trial being conducted?
This trial is being conducted at Ouagadougou, Burkina Faso, Ouagadougou, Burkina Faso, Yaoundé, Cameroon, Abidjan, Côte d’Ivoire and 10 additional locations.
Who is sponsoring the NCT03803735 clinical trial?
NCT03803735 is sponsored by French Africa Pediatric Oncology Group. The principal investigator is Brenda Mallon, MSc at French Africa Pediatric Oncology Group. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.